“Additional Beneficial Effects of Recombinant Growth Hormone in Alendronate-Trated Patients With Idiopathic Osteoporosis”. Actualizaciones En Osteología, vol. 6, no. 2, July 2024, pp. 93-94, https://ojs.osteologia.org.ar/aaomm/index.php/osteologia/article/view/509.